StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$156.23−1.49 (-0.94%)

Close on Nov 18, 2026Market cap $6.15BP/E –Yield –

Belite Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$37.06M. The highest annual figure on record is -$7.55M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$37.06M–
FY2024Dec 31, 2024-$29.35M–
FY2023Dec 31, 2023-$29.90M–
FY2022Dec 31, 2022-$11.85M–
FY2021Dec 31, 2021-$7.55M–

More Belite Bio figures

See a number that looks wrong?